FDA Clearance Tracker · K180577
BioPlex 2200 25-OH Vitamin D Kit
Last checked: Nov 19, 2026Latest source record: Jun 22, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Jun 22, 2018
Substantially Equivalent
Time to decision
109 days
Received Mar 5, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K180577
- Device name
- BioPlex 2200 25-OH Vitamin D Kit
- Applicant
- Bio-Rad Laboratories
- Applicant location
- Benicia, CA
- Received
- Mar 5, 2018
- Decided
- Jun 22, 2018
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- System, Test, Vitamin D (MRG)
- Device class
- Class II
- Regulation
- 21 CFR 862.1825
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MRG. The earliest in FDA's data is K953567, decided Sep 25, 1996.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K180577
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Bio-Rad Laboratories
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- BioPlex 2200 Lyme Total510(k)
K183446 · Decided Mar 12, 2019 · 90 days after receipt
Device type: Reagent, Borrelia Serological Reagent (LSR) · Laboratory Medicine & Pathology
K181661 · Decided Feb 13, 2019 · 233 days after receipt
Device type: Bcr/Abl1 Monitoring Test (OYX) · Laboratory Medicine & Pathology
K171664 · Decided Sep 13, 2017 · 100 days after receipt
Device type: Abnormal Hemoglobin Quantitation (GKA) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.